MSB 2.17% $1.13 mesoblast limited

Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease, page-3

  1. 2,702 Posts.
    lightbulb Created with Sketch. 475
    Here we go. Pure desperation here.

    Great opportunity to sell if it does actually pop on this nothing news.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.